UBS Rates Quantinuum (QNT) buy, $93 Price Target
UBS analyst David Vogt maintains a Buy rating on QNT with a price target of $93, a 13.78% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
UBS rated Quantinuum Inc. ($QNT) "buy" with a $93 price target on June 29, 2026.
Since the rating, $QNT is up 14.2% after 1 week, down 35.0% after 1 month and down 49.8% to date (from the $72.84 close on Jun 29, 2026).
Key Points
- UBS reiterated its Buy rating on QNT, setting a price target of $93 as of June 29, 2026.
- UBS's $93 price target implies 13.78% upside from Quantinuum Inc.'s ($QNT) current $81.74 share price.
- Shares of QNT traded at $75.57 on Monday, with multiple analysts initiating Buy ratings and targets ranging from $90 to $155.
- Insiders, including CFO Nitesh Sharan, bought shares in early June at $60 each.
Get $QNT trade alerts by text
We text you when insiders, Congress or big funds trade $QNT. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Quantinuum Inc. alert may contain errors. Disclosures
On June 29, 2026, UBS analyst David Vogt reiterated his Buy rating on QNT, setting a price target of $93. This reaffirmation comes as QNT shares traded around $75.57 on Monday.
UBS vs. the S&P 500
Hypothetical returns from UBS's disclosed trades, not real profit or advice. How we model this.
Analysts Set New Price Targets
On June 29, 2026, UBS initiated coverage on QNT with a Buy rating and a $93 price target. JP Morgan also started coverage with a Buy rating and a $97 target. Jefferies, Cantor Fitzgerald, and Mizuho each initiated with Buy ratings, setting price targets at $90. Meanwhile, Craig-Hallum and Evercore ISI Group offered Buy ratings with targets of $100 and $98, respectively. Notably, Rosenblatt set a higher target of $155, also with a Buy rating.
Insider Buying and Selling at Quantinuum Inc.
In early June, several insiders bought shares of QNT. On June 5, 2026, Michal Stepniak purchased 13,333 shares, while Joseph Jimenez acquired 66,665 shares, both at $60 each. Vimal Kapur and Eric Branderiz also bought 13,000 and 8,334 shares, respectively, at the same price. Additionally, Prineha Narang and Chief Financial Officer Nitesh Sharan bought 200 and 6,500 shares, respectively, each transaction occurring at $60 per share.
Bottom Line
UBS's reiteration of a Buy rating on QNT with a $93 target reflects continued confidence in the stock's potential. Multiple analysts have initiated coverage with Buy ratings, suggesting broad optimism. Insider buying in early June further indicates positive sentiment from within the company. As always, investors should note that analyst ratings are forward-looking and reflect expectations that may not materialize.
$QNT price target
Quantinuum Inc. daily closes and this analyst's $93 target. Not advice.
Source: UBS's rating change on $QNT (Jun 29, 2026). Written by software, not financial advice. How we make alerts
